Trak

company

About

Sandstone Diagnostics provides an integrated wellness technology that empowers consumers to measure, monitor, and improve their health.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$2.50M
Industries
Biotechnology,Health Care,Health Diagnostics,Wellness
Founded date
Apr 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Sandstone Diagnostics is a Bay Area biotech company developing instruments and consumables for point-of-care medical testing. Sandstone’s lead product, Trak, is a consumer semen analysis platform that provides a simple and accurate way to monitor sperm quality from the comfort of home.

Trak is a tool for men to take charge of their fertility, boost their sperm quality, and improve their chances of conception. Sandstone was co-founded in 2012 by Ph.D. scientists developing medical technologies for national defense applications at Sandia National Laboratories.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$10.10M
Trak has raised a total of $10.10M in funding over 2 rounds. Their latest funding was raised on May 6, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 6, 2019 Series A $2.50M 1 Detail
Jan 16, 2018 Series A $5.80M 1 Detail
Jun 25, 2014 Angel $1.80M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
Trak is funded by 3 investors. LabCorp and DPW Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
LabCorp Series A
DPW Holdings Series A
Treasure Valley Angel Fund Angel